Published • loading... • Updated
Part B Negotiated Drug Prices: How MA Plans Should Prepare
Summary by avalerehealth.com
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
Part B Negotiated Drug Prices: How MA Plans Should Prepare
On January 1, 2028, certain Part B drugs will be subject to negotiated maximum fair prices (MFPs) for the first time ever, per the Inflation Reduction Act (IRA). This is a significant inflection point: Part B drug negotiation introduces a new layer of operational and financial complexity, particularly for Medicare Advantage (MA) plans. The drugs selected for Initial Price Applicability Year (IPAY) 2028 are currently prescribed to roughly 1.8 mil…
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
